NTLA-2002
intellia therapeutics,crispr
['intellia', '$ntla', 'crispr']
1/ presented great results from its phase 1 #clinicaltrail of $ntla-2002 in-vivo #crispr #geneediting platform aimed to treat hereditary angioedema-#hae by knocking out the #klkb1 #gene in #liver #cells &amp; prevent production of kallikrein protein. #biotech #eha2023 
#Science & #Innovation. Special interest in #BioTech, #GeneEditing, #EpiGeneticEditing, #GeneTherapy 🧬 #CRISPR & #Ophthalmology. #Markets & #Stocks 📈